Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harten

Showing results (251-260 of 863) with videos related to

Pageof 87
Sort By:
British Journal of Clinical Pharmacology|December 1, 1990
Pharmacokinetics of eltoprazine in healthy male subjects after single dose oral and intravenous administrationM Raghoebar, M Mak, A Cournot, et al.
Future Science OA|November 23, 2024
DNA sequencing in oncology: a focus group study on a duty to recontactNoor A A Giesbertz, Lars S Assen, Wim H van Harten, et al.
Journal of Magnetic Resonance Imaging : JMRI|August 29, 2024
Quantitative Analysis of Small Intestinal Motility in 3D Cine-MRI Using Centerline-Aware Motion EstimationLouis D van Harten, Catharina S de Jonge, Femke Struik, et al.
Clinical Pharmacology and Therapeutics|May 1, 1985
Nifedipine: influence of renal function on pharmacokinetic/hemodynamic relationshipC H Kleinbloesem, P van Brummelen, J van Harten, et al.
BMC Cancer|November 23, 2024
Relevant factors for policy concerning comprehensive genomic profiling in oncology: stakeholder perspectivesLucas Frederik van Schaik, Ellen Gurumay Engelhardt, Wim Herbert van Harten, et al.
Head and Neck Pathology|September 12, 2020
Small and Thin Oral Squamous Cell Carcinomas may Exhibit Adverse Pathologic Prognostic FeaturesMutaz Mohammed Nur, Maimuna Al Saadi, Esther M O'Regan, et al.
Journal of Child and Adolescent Psychopharmacology|December 14, 2012
Risk of hyperprolactinemia and sexual side effects in males 10-20 years old diagnosed with autism spectrum disorders or disruptive behavior disorder and treated with risperidoneYvette Roke, Jan K Buitelaar, Annemieke M Boot, et al.
The Oncologist|September 18, 2012
Effectiveness of multidimensional cancer survivor rehabilitation and cost-effectiveness of cancer rehabilitation in general: a systematic reviewJanne C Mewes, Lotte M G Steuten, Maarten J Ijzerman, et al.
Clinical Pharmacology and Therapeutics|March 1, 1988
Pharmacokinetics and hemodynamic effects of nisoldipine and its interaction with cimetidineJ van Harten, P van Brummelen, M T Lodewijks, et al.
Breast (Edinburgh, Scotland)|May 5, 2015
Early stage cost-effectiveness analysis of a BRCA1-like test to detect triple negative breast cancers responsive to high dose alkylating chemotherapyAnna Miquel-Cases, Lotte M G Steuten, Valesca P Retèl, et al.
Pageof 87

Showing results (251-260 of 863) with videos related to

Sort By:
Pageof 87
British Journal of Clinical Pharmacology|December 1, 1990
Pharmacokinetics of eltoprazine in healthy male subjects after single dose oral and intravenous administrationM Raghoebar, M Mak, A Cournot, et al.
Future Science OA|November 23, 2024
DNA sequencing in oncology: a focus group study on a duty to recontactNoor A A Giesbertz, Lars S Assen, Wim H van Harten, et al.
Journal of Magnetic Resonance Imaging : JMRI|August 29, 2024
Quantitative Analysis of Small Intestinal Motility in 3D Cine-MRI Using Centerline-Aware Motion EstimationLouis D van Harten, Catharina S de Jonge, Femke Struik, et al.
Clinical Pharmacology and Therapeutics|May 1, 1985
Nifedipine: influence of renal function on pharmacokinetic/hemodynamic relationshipC H Kleinbloesem, P van Brummelen, J van Harten, et al.
BMC Cancer|November 23, 2024
Relevant factors for policy concerning comprehensive genomic profiling in oncology: stakeholder perspectivesLucas Frederik van Schaik, Ellen Gurumay Engelhardt, Wim Herbert van Harten, et al.
Head and Neck Pathology|September 12, 2020
Small and Thin Oral Squamous Cell Carcinomas may Exhibit Adverse Pathologic Prognostic FeaturesMutaz Mohammed Nur, Maimuna Al Saadi, Esther M O'Regan, et al.
Journal of Child and Adolescent Psychopharmacology|December 14, 2012
Risk of hyperprolactinemia and sexual side effects in males 10-20 years old diagnosed with autism spectrum disorders or disruptive behavior disorder and treated with risperidoneYvette Roke, Jan K Buitelaar, Annemieke M Boot, et al.
The Oncologist|September 18, 2012
Effectiveness of multidimensional cancer survivor rehabilitation and cost-effectiveness of cancer rehabilitation in general: a systematic reviewJanne C Mewes, Lotte M G Steuten, Maarten J Ijzerman, et al.
Clinical Pharmacology and Therapeutics|March 1, 1988
Pharmacokinetics and hemodynamic effects of nisoldipine and its interaction with cimetidineJ van Harten, P van Brummelen, M T Lodewijks, et al.
Breast (Edinburgh, Scotland)|May 5, 2015
Early stage cost-effectiveness analysis of a BRCA1-like test to detect triple negative breast cancers responsive to high dose alkylating chemotherapyAnna Miquel-Cases, Lotte M G Steuten, Valesca P Retèl, et al.
Pageof 87